Propylthiouracil
Propylthiouracil (PTU) is an antithyroid medicine used to treat hyperthyroidism, particularly Graves’ disease, and to control excessive thyroid hormone production in selected patients. It works by inhibiting thyroid peroxidase, reducing the synthesis of thyroid hormones, and also limiting the conversion of thyroxine (T4) into the more active triiodothyronine (T3) in peripheral tissues. It is available mainly as oral tablets and may be used in thyroid storm as part of hospital-based combination treatment. Common side effects include nausea, rash, itching, joint pain, and changes in taste. Serious risks include severe liver injury, low white blood cell counts (agranulocytosis), and vasculitis; patients should seek urgent medical attention for symptoms such as jaundice, dark urine, fever, or sore throat. Because of its potential for liver toxicity, PTU is generally reserved for specific situations, such as the first trimester of pregnancy or when other antithyroid medicines are unsuitable, and requires medical supervision and appropriate monitoring.
Propylthiouracil was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Propylthiouracil, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Propylthiouracil from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Propylthiouracil, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
